Detalhe da pesquisa
1.
Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma.
Cell
; 171(2): 481-494.e15, 2017 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28985567
2.
Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma.
Blood
; 139(12): 1863-1877, 2022 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34932792
3.
Immune cell constitution in the tumor microenvironment predicts the outcome in diffuse large B-cell lymphoma.
Haematologica
; 106(3): 718-729, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32079690
4.
Prognostic implications of the microenvironment for follicular lymphoma under immunomodulation therapy.
Br J Haematol
; 189(4): 707-717, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32012230
5.
Adverse prognostic impact of regulatory T-cells in testicular diffuse large B-cell lymphoma.
Eur J Haematol
; 105(6): 712-721, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32632935
6.
T-cell inflamed tumor microenvironment predicts favorable prognosis in primary testicular lymphoma.
Haematologica
; 104(2): 338-346, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30237271
7.
Clinical features and outcome of the patients with sinonasal tract diffuse large B-cell lymphoma in the pre-rituximab and rituximab eras.
Eur J Haematol
; 102(6): 457-464, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30834564
8.
Lenalidomide-bendamustine-rituximab in patients older than 65 years with untreated mantle cell lymphoma.
Blood
; 128(14): 1814-1820, 2016 10 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27354719
9.
PD-L1+ tumor-associated macrophages and PD-1+ tumor-infiltrating lymphocytes predict survival in primary testicular lymphoma.
Haematologica
; 103(11): 1908-1914, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30026337
10.
TET2 mutations in B cells of patients affected by angioimmunoblastic T-cell lymphoma.
J Pathol
; 242(2): 129-133, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28337768
11.
Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years.
Biol Blood Marrow Transplant
; 23(3): 428-435, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28039078
12.
miR-18b overexpression identifies mantle cell lymphoma patients with poor outcome and improves the MIPI-B prognosticator.
Blood
; 125(17): 2669-77, 2015 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-25736311
13.
Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3.
Blood
; 125(4): 639-48, 2015 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-25349174
14.
15-year follow-up of the Second Nordic Mantle Cell Lymphoma trial (MCL2): prolonged remissions without survival plateau.
Br J Haematol
; 175(3): 410-418, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27378674
15.
Nordic MCL3 study: 90Y-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma.
Blood
; 123(19): 2953-9, 2014 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-24652994
16.
Clinical findings of extranodal SNT lymphoid malignancies in a four-decade single-centre series.
Eur Arch Otorhinolaryngol
; 273(11): 3839-3845, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27010643
17.
Primary mediastinal large B-cell lymphoma segregating in a family: exome sequencing identifies MLL as a candidate predisposition gene.
Blood
; 121(17): 3428-30, 2013 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-23457195
18.
Prognostic influence of macrophages in patients with diffuse large B-cell lymphoma: a correlative study from a Nordic phase II trial.
Haematologica
; 100(2): 238-45, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25381134
19.
Constant pattern of relapse in primary central nervous lymphoma patients treated with high-dose methotrexate combinations. A Finnish retrospective study.
Acta Oncol
; 54(6): 939-43, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25761092
20.
[Febrile episodes of unknown origin, elevated level of plasma ferritin and rapidly developed multiorgan dysfunction]. / Epäselvä kuumeilu, suurentunut plasman ferritiinipitoisuus ja nopeasti kehittynyt monielinvaurio.
Duodecim
; 130(3): 269-77, 2014.
Artigo
em Fi
| MEDLINE | ID: mdl-24660387